Dr Daniel Krell

Dr-Daniel-Krell

Dr Daniel Krell

DPHIL, MRCP, MBCHB, BSC

Consultant Medical Oncologist

Dr Daniel Krell qualified in medicine at Leeds University Medical School, where he also gained a Bachelor’s degree in immunology and microbiology. He completed his junior doctor training at Leeds General infirmary in Leeds and at Guys and St. Thomas’ Hospitals and University College Hospital in London before undertaking his oncology training at The Royal Free and University College Hospitals in London.

Dr Krell’s DPhil research was undertaken at The University of Oxford, Wellcome Trust Centre for Human Genetics, and was funded by Cancer Research UK and HCA. Dr Krell’s research investigated the role that genetic mutations in genes controlling cellular metabolism play in the development of cancer, with a view to identifying new therapeutic targets in this area. He continues to be involved in clinical research and clinical trials aimed at identifying new cancer therapies, with a focus on gastrointestinal and hepatobiliary malignancies.
Dr Krell has published in several peer-reviewed papers in journals such as the British Journal of Cancer and Lancet Oncology, and has submitted and presented abstracts and posters at national and international conferences.

His clinical work focuses on the management of patients with gastro-oesophageal, colorectal, pancreatic, liver and biliary tract cancers using chemotherapy, targeted therapy and immunotherapies. He also manages patients with cancer of unknown primary and is the clinical lead at Barnet hospital for this. He also acts as the MDT lead for gastro-oesophageal and hepatobiliary cancer at his institution. He is also a member of the London cancer expert reference group for acute oncology and cancer of unknown primary.

Year qualified

2003


Country of qualification

UK


Languages spoken

English


Specialities

  • Oncology
  • Medical Oncology


Memberships

  • Royal College of Physicians


Procedures offered

Chemotherapy, targeted therapy and immunotherapy for the treatment of Gastrointestinal and hepatobiliary cancer


Clinical interests

  • The systemic treatment of colorectal, gastro-oesophageal, pancreatic and liver and bile duct cancers and cancer of unknown primary
  • Clinical lead for cancer of unknown primary
  • MDT lead for upper gastro-intestinal cancer at Barnet hospital


 

Research interests

DPhil in clinical medicine obtained from the Wellcome Trust Centre for Human Genetics, University of Oxford. Establishing links between genetic mutations in genes involved in cellular metabolism and the development of cancer. Involvement in clinical trials of new therapies for gastrointestinal and hepatobiliary cancers.


Dr Daniel Krell, Consultant Medical Oncologist is available to be seen for consultations at Royal Free London

192 14_022_PPU 1 Publicity1211

Make an enquiry online using this form and one of our team will be in touch. By using this form you agree with the storage and handling of your data by our team.